StockData
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

biote Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$1.08−0.00 (-0.46%)

Close on Oct 19, 2026

Market cap
$30.92M
P/E (TTM)
10.8
Dividend yield
–

biote Corp. revenue by segment

By business segment

By product or service

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23% of revenueYoY
Product Revenue$179.52M$183.79M$186.92M$189.92M$192.78M$193.23M$192.24M$188.89M$183.91M$184.45M$182.57M$181.65M97.8%-6.9%
Pellet Procedures Product Revenue$127.39M$132.29M$137.04M$141.81M$145.77M$148.98M$150.33M$148.60M$146.09M$143.31M$140.99M$138.83M69.4%-12.6%
Dietary Supplements$45.26M$44.65M$42.88M$41.27M$40.41M$37.90M$36.02M$35.08M$33.24M$37.15M$38.09M$39.65M24.7%+12.0%
Disposable Trocars Product Revenue$4.79M$4.81M$4.85M$4.77M$4.61M$4.49M$4.35M$4.11M$3.92M$3.63M$3.32M$3.03M2.6%+3.9%
Service Revenue$4.01M$4.37M$5.30M$5.72M$6.30M$6.15M$4.95M$4.17M$3.32M$2.87M$2.79M$2.49M2.2%-36.3%
Shipping Fees And Other Product Revenue$2.08M$2.05M$2.15M$2.08M$1.99M$1.86M$1.55M$1.10M$666.00K$367.00K$172.00K–1.1%+4.3%
Other Service Revenue$2.00M$2.13M$2.86M$3.15M$3.42M$3.35M$2.27M$1.60M$1.07M$776.00K$697.00K–1.1%-41.5%
Contract-Term Services Revenue$1.33M$1.36M$1.36M$1.38M$1.34M$1.29M$1.23M$1.12M$1.05M$984.00K$920.00K$876.00K0.7%-0.2%
Training Service Revenue$681.00K$880.00K$1.08M$1.20M$1.54M$1.51M$1.46M$1.46M$1.20M$1.11M$1.17M$1.13M0.4%-55.9%
Shipping Fees Product Revenue–––––––––$196.00K$172.00K$147.00K––

By region

From the segment and revenue-disaggregation notes of biote's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.